Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory pragmatic trial of fosfomycin trometamol for male urinary tract infections in primary care
2023-510355-36-00Phase 3Authorised
- Sponsor
- Rouen University Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of fosfomycin in urinary tract infection (UTI), sponsored by Rouen University Hospital. Primary endpoint: Primary endpoint: absence of clinical treatment failure up to 14 days after end of antibiotic treatment. Planned start Oct 2024; status: authorised.
02
Drugs
fosfomycin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2023-510355-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510355-36-00.